Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-Informed Machine Learning
The safety of inorganic nanoparticles (NPs) remains a critical challenge for their clinical translation. To address this, we developed a machine learning (ML) framework that predicts NP toxicity both <i>in vitro</i> and <i>in vivo</i>, leveraging physicochemical properties and experimental conditions. A curated <i>in vitro</i> cytotoxicity dataset was used to train and validate binary classification models, with top-performing models undergoing explainability analysis to identify key determinants of toxicity and establish structure-toxicity relationships. External testing with diverse inorganic NPs validated the predictive accuracy of the framework for <i>in vitro</i> settings. To enable organ-specific toxicity predictions <i>in vivo</i>, we integrated a physiologically based pharmacokinetic (PBPK) model into the ML pipeline to quantify NP exposure across organs. Retraining the ML models with PBPK-derived exposure metrics yielded robust predictions of organ-specific nanotoxicity, further validating the framework. This PBPK-informed ML approach can thus serve as a potential alternative approach to streamline NP safety assessment, enabling the rational design of safer NPs and expediting their clinical translation.
Authors
- C. Jeffrey Brinker (ORCID: https://orcid.org/0000-0002-7145-9324)
- Renata Pasqualini (ORCID: https://orcid.org/0000-0002-4155-9324)
- Carmine Schiavone
- Vittorio Cristini (ORCID: https://orcid.org/0000-0002-7909-4278)
- Matthew J. Campen (ORCID: https://orcid.org/0000-0002-2292-5050)
- Wadih Arap (ORCID: https://orcid.org/0000-0002-8686-4584)
- Prashant Dogra (ORCID: https://orcid.org/0000-0001-6722-7371)
- Daniela I. Staquicini
- Achraf Noureddine (ORCID: https://orcid.org/0000-0001-9530-5963)
- Henry J. Pownall (ORCID: https://orcid.org/0000-0001-8412-506X)
- Zhihui Wang (ORCID: https://orcid.org/0000-0001-6262-700X)
- Joseph Cave (ORCID: https://orcid.org/0000-0002-0177-875X)
- Hien Van Nguyen (ORCID: https://orcid.org/0000-0001-7280-2182)
- Anne Christiono
Institutions
- Rutgers, The State University of New Jersey (US)
- Houston Methodist (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of New Mexico (US)
- Cornell University (US)
- Cancer Institute (WIA) (IN)
- Rutgers Sexual and Reproductive Health and Rights (NL)
- Methodist Hospital (US)
- Weill Cornell Medicine (US)
- Rutgers New Jersey Medical School (US)
- University of Houston (US)
- Massachusetts Institute of Technology (US)
- University of Naples Federico II (IT)
Publication Details
- Journal
- ACS Nano
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1021/acsnano.5c03590
- Citations
- 12
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 7.17
Funders
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering